Skip to main content

Table 5 Showing genotypic and allelic distribution of selected gene polymorphisms among cases and controls

From: “Association of MTHFR and MS/MTR gene polymorphisms with congenital heart defects in North Indian population (Jammu and Kashmir): a case–control study encompassing meta-analysis and trial sequential analysis”

Category

Genotypes/Alleles (%)

χ2

p-value

MTHFR (C677T) polymorphism

CC (Wild)

CT (Hetero)

TT

(Risk)

C

(Wild)

T

(Risk)

CHD Cases (n = 50)

44 (88%)

4

(8%)

2

(4%)

0.92

0.08

10.42

0.001*

Controls (n = 100)

90 (90%)

9

(9%)

1

(1%)

0.95

0.05

1.8

0.18

 

MTHFR (G1793A) polymorphism

  

GG (Wild)

GA (Hetero)

AA (Risk)

G (Wild)

A (Risk)

CHD Cases (n = 50)

29 (58%)

19 (38%)

2 (4%)

0.77

0.23

0.27

0.61

Controls (n = 100)

90 (90%)

10 (10%)

0

0.95

0.05

0.28

0.60

 

MS (A2756G) gene polymorphism

  

AA (Wild)

AG (Hetero)

GG (Risk)

A (Wild)

G (Risk)

CHD Cases (n = 50)

30 (60%)

18 (36%)

2 (4%)

0.78

0.22

0.12

0.73

Controls (n = 100)

73 (73%)

26 (26%)

1 (1%)

0.86

0.14

0.64

0.43